Regarding CD4 CTLs (C13 cluster), 74.4% of this population were from the blood of PD patients, and this percentage increased to 77.3% when the background was reduced to clonally expanded CD4 CTLs (Fig. 4f). The gene discussed is CD4; the disease is Parkinson disease.